NEW YORK (Reuters Health) – Brief augmented psychodynamic interpersonal therapy can abolish psychogenic nonepileptic seizures (PNES) or significantly reduce their frequency in many instances, a British team has…
Avraham I. Rivkind, M.D., Head of the Department of General Surgery and Shock Trauma Unit at Hadassah University Hospital Ein-Karem, discusses new developments at Hadassah in the field…
NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Dizziness in the elderly is caused by cardiovascular disease in over half of patients seen in primary care, according to new research from…
NEW YORK (Reuters Health) – In new recommendations for the management of vulvodynia, the British Society for the Study of Vulval Diseases Guideline Group stresses a team approach…
NEW YORK (Reuters Health) – Contradictory findings in two trials of divalproex sodium extended-release (ER) for acute mania shed light on design features to consider for future studies…
NEW YORK (Reuters Health) – Elderly patients who use antipsychotic agents are at increased risk for community-acquired pneumonia, a report from The Netherlands indicates. Moreover, as the drug…
NEW YORK (Reuters Health) – Pooled data from multiple studies indicate that repetitive transcranial magnetic stimulation (rTMS) is useful for depression, auditory verbal hallucinations, and possibly for negative…
NEW YORK (Reuters Health) – Patients starting clozapine must be monitored for endocarditis during the first month, particularly at week 3, new research shows. The researchers also suggest…
NEW YORK (Reuters Health) – Sertraline plus naltrexone is more effective than either agent alone in promoting abstinence in depressed alcohol-dependent patients, according to study findings in the…